Levofloxacin injection is indicated for the treatment of adults (≥ 18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms in the conditions listed in this section. Before taking this medicine. You should not use this medicine if you are allergic to levofloxacin or other fluoroquinolones (ciprofloxacin, gemifloxacin, moxifloxacin, norfloxacin, ofloxacin, and others). 1 No additional doses are required after haemodialysis or continuous ambulatory peritoneal dialysis (CAPD). Patients with hepatic impairment. No adjustment of dose is required since levofloxacin is not metabolised to any relevant extent by the liver and is mainly excreted by the kidneys. Summary. Levofloxacin (Levaquin - brand discontinued) is an antibiotic for treating bacterial infections of the sinuses, skin, lungs, ears, bones, airways, and joints. Medical uses. Levofloxacin is used to treat infections including: respiratory tract infections, cellulitis, urinary tract infections, prostatitis, anthrax, endocarditis, meningitis, pelvic inflammatory disease, traveler's diarrhea, tuberculosis, and plague and is available by mouth, intravenously, and in eye drop form. Avoid use of systemic quinolones, such as levofloxacin, in patients with a history of myasthenia gravis. Systemic quinolones may exacerbate the signs of myasthenia gravis and lead to life threatening weakness of the respiratory muscles. Drug Information on Levaquin, Levaquin Leva-Pak (levofloxacin (oral)) includes drug pictures, side effects, drug interactions, directions for use, symptoms of overdose, and what to avoid. Find patient medical information for Levofloxacin Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Antibiotic Levofloxacin (Levaquin) 750 mg, 500 mg for the treatment of respiratory, skin, and urinary tract infections, user reviews and ratings. Levofloxacin ist ein antibiotisch wirksamer Arzneistoff. Chemisch handelt es sich um ein Fluorchinolon der dritten Generation. Levofloxacin kam 1993 in Japan und 1998 in Deutschland auf den Markt, in den USA wurde es 1996 durch die FDA zugelassen. Die FDA informierte 2008 und 2013 über neu beobachtete schwere Nebenwirkungen bei systemisch.